EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

Sharif Arar, Md Anzarul Haque, Rakez Kayed

Proteins: Structure, Function, and Bioinformatics · 2025-08 · 93 (8) · 1314-1329

DOI: 10.1002/prot.26561 ↗

At a glance

Übersichtsarbeit in Proteins: Structure, Function, and Bioinformatics, published online on 2023-08-02. Written by Sharif Arar and 2 co-authors. Institution: Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, USA. Major MEDLINE topics: Intrinsically Disordered Proteins, Alzheimer Disease, Neurodegenerative Diseases, Protein Aggregates. Cited 17 times so far (Crossref); 296 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIA NIH HHS, National Institute of Health USA, Mitchell Center for Neurodegenerative Diseases.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Before the controversial approval of humanized monoclonal antibody lecanemab, which binds to the soluble amyloid‐β protofibrils, all the treatments available earlier, for Alzheimer's disease (AD) were symptomatic. The researchers are still struggling to find a breakthrough in AD therapeutic medicine, which is partially attributable to lack in understanding of the structural information associated with the intrinsically disordered proteins and amyloids. One of the major challenges in this area of research is to understand the structural diversity of intrinsically disordered proteins under in vitro conditions. Therefore, in this review, we have summarized the in vitro applications of biophysical methods, which are aimed to shed some light on the heterogeneity, pathogenicity, structures and mechanisms of the intrinsically disordered protein aggregates associated with proteinopathies including AD. This review will also rationalize some of the strategies in modulating disease‐relevant pathogenic protein entities by small molecules using structural biology approaches and biophysical characterization. We have also highlighted tools and techniques to simulate the in vivo conditions for native and cytotoxic tau/amyloids assemblies, urge new chemical approaches to replicate tau/amyloids assemblies similar to those in vivo conditions, in addition to designing novel potential drugs.

Subjects

MeSH terms (MEDLINE)

Intrinsically Disordered ProteinsAlzheimer DiseaseNeurodegenerative DiseasesProtein AggregatesProtein Aggregation, PathologicalHumanstau ProteinsAmyloid beta-PeptidesAnimals

Author keywords

Alzheimer's diseaseamyloidsbiophysical methodsdrug developmentimmunotherapy

Substances

Intrinsically Disordered Proteinstau ProteinsAmyloid beta-PeptidesProtein Aggregates

Authors and institutions

  • Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, USA.
  • Departments of Neurology, Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Department of Chemistry, School of Science, The University of Jordan, Amman, Jordan.

Funding

  • NIA NIH HHS
  • National Institute of Health USA
  • Mitchell Center for Neurodegenerative Diseases
  • University of Jordan
  • Fulbright Visiting Scholar Program
  • Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch

Cite

APA

Arar, S., Haque, M. A., & Kayed, R. (2025). Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics. Proteins: Structure, Function, and Bioinformatics, 93(8), 1314-1329. https://doi.org/10.1002/prot.26561

Vancouver

Arar S, Haque MA, Kayed R. Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics. Proteins: Structure, Function, and Bioinformatics. 2025;93(8):1314-1329. doi:10.1002/prot.26561

BibTeX
@article{Arar2025,
  author = {Arar, Sharif and Haque, Md Anzarul and Kayed, Rakez},
  title = {Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics},
  journal = {Proteins: Structure, Function, and Bioinformatics},
  year = {2025},
  volume = {93},
  number = {8},
  pages = {1314--1329},
  doi = {10.1002/prot.26561}
}
Start for free →